Today’s article features two biotech stocks that analysts believe have the potential to double over the next 12 months. The first company is developing therapies and vaccines that are focused on critical unmet needs in oncology and infectious disease while the second is developing novel therapeutics to treat diseases caused by protein misfolding, including rare genetic diseases and neurological disorders. For these two stocks, CLICK HERE.
2 Potential Biotech Doublers
- by RobH